Gene | Genotype | Lung cancer patients (SOD levels) | p value | Controls (SOD levels) | p value | Total p value | ||
---|---|---|---|---|---|---|---|---|
n | Mean ± SE | n | Mean ± SE | |||||
CYP1A1, m1 | T/T | 121 | 914.28 ± 30.05 |  | 138 | 1166.08 ± 12.8 |  | 0.92 |
 | T/C | 89 | 915.73 ± 17.03 | 0.45 | 98 | 1165.71 ± 13.93 | 0.35 | 0.14 |
 | C/C | 28 | 910.74 ± 13.57 | 0.62 | 14 | 1070.00 ± 37.60 | 0.78 | 0.65 |
CYP1A1, m2 | A/A | 71 | 922.25 ± 18.18 |  | 196 | 1190.00 ± 10.61 |  | <0.01* |
 | A/G | 156 | 909.87 ± 12.00 | 0.81 | 34 | 1165.91 ± 20.61 | 0.14 | 0.05* |
 | G/G | 11 | 898.18 ± 67.01 | 0.07 | 20 | 1080.58 ± 23.82 | 0.08 | 0.02* |
GSTM1 | +/+ | 174 | 927.01 ± 11.81 |  | 187 | 1214.54 ± 7.47 |  | <0.01* |
 | –/– | 64 | 875.00 ± 18.00 | 0.56 | 63 | 1175.71 ± 10.72 | 0.15 | <0.01* |
GSTT1 | +/+ | 192 | 929.58 ± 10.57 |  | 224 | 1168.03 ± 9.86 |  | 0.91 |
 | –/– | 46 | 843.91 ± 24.69 | 0.04* | 26 | 1096.12 ± 23.16 | 0.10 | 0.05* |